Relaxation susceptibility MRI characteristics in Hallervorden-Spatz syndrome

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 4, 2007, Pages 715-720

  Desai, Sunali Vinod ^a,b   Bindu, Parayil Shankaran ^a   Ravishankar, Shivasankar ^a   Jayakumar, Peruvumba Narayan ^a,b   Pal, Pramod Kumar ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b MANIPAL UNIVERSITY   (India)

Author keywords

BOLD; FLASH; Hallervorden Spatz syndrome; MR imaging; Proton spectroscopy; SWI

Indexed keywords

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REVIEW; SIGNAL PROCESSING; SUSCEPTIBILITY WEIGHTED IMAGING;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN; CHILD; FEMALE; HALLERVORDEN-SPATZ SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 34047092826     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20830     Document Type: Review

References (25)

1. Dooloing EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 1974;30:70-83.
2. Hallervorden J, Spatz H. Unique disease of the extrapyramidal system with particular involvement of the globus pallidus and the substantia nigra [in German]. Z Ges Neurol Psychiatr 1922;79: 254-302.
3. Vymazal J, Brooks RA, Baumgarner C, et al. The relation between brain iron and NMR relaxation times: an in vitro study, Magn Reson Med 1996;35:56-61,
4. Taylor TD, Litt M, Kramer P, et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13, Nat Genet 1996;14:479-481.
5. Guillerman RP. The eye-of-the-tiger sign. Radiology 2000;217:895-896.
6. Liang L, Korogi Y, Sugahara T, et al. Detection of intracranial hemorrhage with susceptibility-weighted MR sequences. AJNR Am J Neuroradiol 1999;20:1527-1534.
7. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-1293.
8. Halliday W. The nosology of Hallervorden-Spatz disease. J Neurol Sci 1995;134(suppl):84-91.
9. Hayflick SJ. First scientific workshop on Hallervorden-Spatz syndrome: executive summary. Pediatr Neurol 2001;25:99-101.
10. Swaiman KF. Hallervorden-Spatz syndrome. Pediatr Neurol 2001; 25:102-108.
11. Zhou B, Westaway SK, Levinson B, Johnson MA, Gistschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK 2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.
12. Ostergaard JR, Christensen T, Hansen KN. In vivo diagnosis of Hallervorden-Spatz disease. Dev Med Child Neurol 1994;37:827-833.
13. Sacks OW, Aguilar MJ, Brown WJ. Hallervorden-Spatz disease. Is pathogenesis and place among the axonal dystrophies. Acta Neuropathol 1966;6:164-174.
14. Jankovic J, Kirkpatric JB, Blomquist A, Langlais PJ, Bird ED. Late onset Hallervorden-Spatz disease presenting as a familial parkinsonism. Neurology 1985;35:227-234.
15. Bradley WG. Pathophysiological correlates of signal alterations. In: Brant-Zwadzki M, Norman D, editors. Magnetic resonance imaging of the central nervous system. New York: Raven Press; 1987: p 1-45.
16. Feliciani M, Curatolo P: Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease. Neuroradiology 1994;36: 247-248,
17. Molinuevo JL, Munoz E, Valldeoriola F, Tolosa E. The eye-of-the-tiger sign in the cortical-basal ganglionic degeneration. Mov Disord 1999;14:169-171.
18. Barbosa ER, Bitar MS, Bacheschi LA, Comerlati LR, Scaff M. Parkinsonismo precoce associado a lesoes pallidais do tip 'eye of the tiger', Arq Neuropsiquiatr 1995;53:294-297.
19. Davie CA, Barker GJ, Machado C, Miller DH, Lees AJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord 1997;12:767-771,
20. Atlas SW, Do HM, Intracranial hemorrhage. In: Atlas SW, editor, 3rd ed. Magnetic resonance imaging of the brain and spine, Philadelphia: Lippincott Williams and Wilkins; 2001. p 833-918,
21. Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 2004;19:36-42.
22. Park B E, Netsky MG, Betsill WL, Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders. Neurology 1975;25:1172-1178,
23. Swaiman KF, Smith SA, Trock GL, et al. Sea-blue histiocytes, lymphocytic cytosomes, movement disorder and 59Fe- uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan? Neurology 1983;33:301-305.
24. Sethi KD, Adams RJ, Loring DW, et al. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692-698.
25. Sener RN. Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings. AJNR Am J Neuroradiol 2003;24:1690-1693.